MA S689 | 2023-2024 | 193rd General Court

Status

Spectrum: Moderate Partisan Bill (Democrat 24-6)
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-06-20 - Accompanied H1074
Text: Latest bill text (Introduced) [PDF]

Summary

For legislation relative to patient access to biomarker testing to provide appropriate therapy. Financial Services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relative to patient access to biomarker testing to provide appropriate therapy

Sponsors


History

DateChamberAction
2024-06-20HouseAccompanied H1074
2024-05-30SenateBill reported favorably by committee and referred to the Joint Committee on Health Care Financing
2024-03-28SenateSenate concurred
2024-02-08HouseReporting date extended to Friday May 17, 2024, pending concurrence
2023-04-28JointHearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium
2023-04-18JointHearing scheduled for 05/02/2023 from 10:00 AM-01:00 PM in A2 and virtual
2023-02-16HouseHouse concurred
2023-02-16SenateReferred to the Joint Committee on Financial Services

Same As/Similar To

S1369 (Similar To) 2024-05-09 - Accompanied a study order, see H4634
H1050 (Similar To) 2024-05-30 - Accompanied a study order, see H4691
H1074 (Similar To) 2024-06-20 - Committee recommended bill ought to pass and referred to the committee on House Ways and Means

Massachusetts State Sources


Bill Comments

feedback